Barclays’s SeaStar Medical ICU Stock Holding History

Barclays’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-583	Closed	-$44.3K	–	5370
2024 Q2	$44.3K	Buy	+583	New	+$62.5K	﹤0.01%	4249

Other funds holding ICU

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TFS

Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Barclays's ICU Position: Q3 2024 in Review

Barclays sold out of SeaStar Medical (ICU) in Q3 2024, closing a stake of 583 shares — an estimated $44.3K sold.

Barclays first reported a position in ICU in Q2 2024 and held it in 1 quarter. The position peaked at $44.3K in Q2 2024. 15 funds tracked by Wall St. Rank hold ICU as of Q3 2024.

Barclays reported no remaining SeaStar Medical position as of Q3 2024 after selling out during the quarter.
Barclays sold 583 SeaStar Medical shares in Q3 2024, an estimated $44.3K.
Barclays first reported a position in SeaStar Medical in Q2 2024 and held it in 1 quarter.
Barclays's SeaStar Medical position peaked at $44.3K in Q2 2024.
15 funds tracked by Wall St. Rank held SeaStar Medical as of Q3 2024.

Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.